Showing results (171-180 of 316) with videos related to

Sort By:
Pageof 32
Blood Advances|October 27, 2020
Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignanciesAmy M Trottier, Lawrence J Druhan, Ira L Kraft, et al.
Leukemia & Lymphoma|December 15, 2010
T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapseVaishalee P Kenkre, Sarah Horowitz, Andrew S Artz, et al.
Cephalalgia : an International Journal of Headache|July 2, 2019
Anxiety sensitivity and intentional avoidance of physical activity in women with probable migraineSamantha G Farris, J Graham Thomas, Ana M Abrantes, et al.
Leukemia & Lymphoma|December 25, 2015
Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessmentChristopher R D'Angelo, Masha Kocherginsky, Jennifer Pisano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantationAndrew S Artz, Amittha Wickrema, Shira Dinner, et al.
Headache|June 6, 2019
Anxiety Sensitivity as a Risk Indicator for Anxiety, Depression, and Headache Severity in Women With MigraineSamantha G Farris, Emily K Burr, Ana M Abrantes, et al.
Cytotherapy|May 3, 2012
Influence of related donor age on outcomes after peripheral blood stem cell transplantationElie M Richa, Rangesh Kunnavakkam, Lucy A Godley, et al.
Epigenetics|March 8, 2012
Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemiaJumpei Yamazaki, Rodolphe Taby, Aparna Vasanthakumar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2011
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantationKoen van Besien, Wendy Stock, Elizabeth Rich, et al.
Cancer Causes & Control : CCC|June 20, 2006
Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States)Jacob H Cohen, Victor J Schoenbach, Jay S Kaufman, et al.
Pageof 32